Literature DB >> 27057401

Combining Stimulants and Monoamine Oxidase Inhibitors: A Reexamination of the Literature and a Report of a New Treatment Combination.

Joshua A Israel1.   

Abstract

This report reviews the medical literature on combining stimulants with monoamine oxidase inhibitors. A case is also presented documenting successful treatment of major depressive disorder and comorbid attention-deficit/hyperactivity disorder using the previously undocumented combination of transdermal selegiline and lisdexamfetamine. This combination should be used cautiously and with ongoing monitoring of heart rate and blood pressure.

Entities:  

Year:  2015        PMID： 27057401      PMCID： PMC4805402          DOI： 10.4088/PCC.15br01836

Source DB:  PubMed          Journal:  Prim Care Companion CNS Disord        ISSN： 2155-7780


  39 in total

1.  DEATH AFTER COMBINED DEXAMPHETAMINE AND PHENELZINE.

Authors:  J T LLOYD; D R WALKER
Journal:  Br Med J       Date:  1965-07-17

Review 2.  Combining stimulants with monoamine oxidase inhibitors: a review of uses and one possible additional indication.

Authors:  S Shalom Feinberg
Journal:  J Clin Psychiatry       Date:  2004-11       Impact factor: 4.384

3.  Treatment of depression with atypical features: a meta-analytic approach.

Authors:  Verena Henkel; Roland Mergl; Antje-Kathrin Allgaier; Ralph Kohnen; Hans-Jürgen Möller; Ulrich Hegerl
Journal:  Psychiatry Res       Date:  2006-01-30       Impact factor: 3.222

4.  Remission in depression: definition and initial treatment approaches.

Authors:  Joshua A Israel
Journal:  J Psychopharmacol       Date:  2006-05       Impact factor: 4.153

Review 5.  Overview of serotonin syndrome.

Authors:  Mohammad M Iqbal; Miles J Basil; Jonathan Kaplan; Md Touhid Iqbal
Journal:  Ann Clin Psychiatry       Date:  2012-11       Impact factor: 1.567

Review 6.  Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.

Authors:  Samantha J Thomas; Mirae Shin; Melvin G McInnis; Jolene R Bostwick
Journal:  Pharmacotherapy       Date:  2015-04       Impact factor: 4.705

7.  Adult ADHD and comorbid depressive disorders: diagnostic challenges and treatment options.

Authors:  David Goodman
Journal:  CNS Spectr       Date:  2009-07       Impact factor: 3.790

8.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

Review 9.  Psychopharmacology and psychotherapy for the treatment of adults with ADHD-a systematic review of available meta-analyses.

Authors:  Tais S Moriyama; Guilherme V Polanczyk; Fernanda S Terzi; Kauy M Faria; Luis A Rohde
Journal:  CNS Spectr       Date:  2013-06-06       Impact factor: 3.790

Review 10.  EMSAM (deprenyl patch): how a promising antidepressant was underutilized.

Authors:  Gregory M Asnis; Margaret A Henderson
Journal:  Neuropsychiatr Dis Treat       Date:  2014-10-06       Impact factor: 2.570
View more
  2 in total

1.  Pharmacological Augmentation in Unipolar Depression: A Guide to the Guidelines.

Authors:  Rachael W Taylor; Lindsey Marwood; Emanuella Oprea; Valeria DeAngel; Sarah Mather; Beatrice Valentini; Roland Zahn; Allan H Young; Anthony J Cleare
Journal:  Int J Neuropsychopharmacol       Date:  2020-12-03       Impact factor: 5.176

2.  Alpha1-Adrenergic Receptor Mediated Long-Term Depression at CA3-CA1 Synapses Can Be Induced via Accumulation of Endogenous Norepinephrine and Is Preserved Following Noradrenergic Denervation.

Authors:  Katie Dyer-Reaves; Anthoni M Goodman; Amy R Nelson; Lori L McMahon
Journal:  Front Synaptic Neurosci       Date:  2019-10-09
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.